CCL5 released from human AML cells has been shown to affect immune cell migration and has been shown to play an essential role in the chemotaxis and homing of AML cells (Weitzenfeld and Ben-Baruch, 2014; Park et al., 2015). This evidence concerns the gene CCL5 and acute myeloid leukemia.